Compare PYPD & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PYPD | ISPR |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.0M | 89.5M |
| IPO Year | 2014 | 2023 |
| Metric | PYPD | ISPR |
|---|---|---|
| Price | $6.55 | $1.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $11.50 | $4.70 |
| AVG Volume (30 Days) | ★ 193.8K | 12.9K |
| Earning Date | 11-11-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.94 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $96,014,610.00 |
| Revenue This Year | N/A | $12.14 |
| Revenue Next Year | N/A | $14.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.50 | $1.01 |
| 52 Week High | $7.15 | $3.87 |
| Indicator | PYPD | ISPR |
|---|---|---|
| Relative Strength Index (RSI) | 66.97 | 46.35 |
| Support Level | $4.26 | $1.23 |
| Resistance Level | $7.15 | $1.65 |
| Average True Range (ATR) | 0.52 | 0.17 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 64.65 | 25.00 |
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded and non-branded vaping hardware products in both the nicotine and cannabis spaces, as well as the assembly of nicotine pouch products and other next-generation nicotine products. The company sells its e-cigarette and pouch products globally, in markets where it is legally permitted to do so. The majority of its nicotine products are marketed under the Aspire brand name, and the cannabis products are marketed under the Ispire brand name. Geographically, the company generates the majority of its revenue from Europe, followed by North America, Asia Pacific, and other markets.